Systemic sclerosis is a multisystem connective tissue disorder characterized by excessive fibrosis of the skin and internal organs. Impairments in skin, the musculoskeletal system, and respiratory system require rehabilitation therapy because they may lead to disabilities and reduce the quality of life in daily activities. Rehabilitation for systemic sclerosis mainly comprises two distinct approaches that include local and global rehabilitation. Local rehabilitation is applied to maintain and/or improve hand and face functions, while global rehabilitation includes aerobic and resistance exercises. Although few high-quality randomized clinical trials have been conducted to date, previous studies indicated the effectiveness of rehabilitation therapy for decreasing local and systemic disabilities, resulting in improved quality of life. Rehabilitation for systemic sclerosis needs to be regularly and constantly performed at home as well as in hospitals. Physicians involved in the treatment of systemic sclerosis need to consider rehabilitation, and skilled physiotherapists and occupational therapists also play a crucial role in evaluating and treating systemic sclerosis patients.
Maddali-BongiSDel RossoA.Systemic sclerosis: rehabilitation as a tool to cope with disability. Clin Exp Rheumatol. 2016;34(Suppl. 100(5)):162-169.
2.
PooleJL.Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol. 2010;22(2):205-212.
3.
AvouacJKowal-BieleckaOLandeweRet al. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis. 2009;68(5):629-634.
4.
PopeJ.Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS). Arthritis Care Res. 2011;63(Suppl. 11):S98-S111.
5.
SteenVDMedsgerTAJr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40(11):1984-1991.
6.
KuwanaMSatoSKikuchiKet al. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol. 2003;30(6):1253-1258.
7.
SilmanAAkessonANewmanJet al. Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol. 1998;25(1):79-83.
8.
SmythAEMacGregorAJMukerjeeDet al. A cross-sectional comparison of three self-reported functional indices in scleroderma. Rheumatology. 2003;42(6):732-738.
9.
EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
10.
StricklandGPaulingJCavillCet al. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin Rheumatol. 2012;31(8):1215-1222.
11.
KhannaDClementsPJFurstDEet al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005;52(2):592-600.
12.
CellaDYountSSorensenMet al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32(5):811-819.
13.
BaronMHudsonMTatibouetSet al. The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology. 2014;53(8):1386-1394.
14.
MouthonLRannouFBerezneAet al. Development and validation of a scale for mouth handicap in systemic sclerosis: the mouth handicap in systemic sclerosis scale. Ann Rheum Dis. 2007;66(12):1651-1655.
15.
Maddali-BongiSDel RossoAMiniatiIet al. The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients. Rheumatol Int. 2012;32(9):2785-2790.
16.
BrowerLMPooleJL.Reliability and validity of the Duruoz hand index in persons with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51(5):805-809.
17.
SandqvistGEklundM.Validity of HAMIS: a test of hand mobility in scleroderma. Arthritis Care Res. 2000;13(6):382-387.
18.
BerettaLSantanielloALemosAet al. Validity of the Saint George’s Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology. 2007;46(2):296-301.
19.
JonesPWHardingGBerryPet al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648-654.
20.
KhannaDTsengCHFurstDEet al. Minimally important differences in the Mahler’s transition dyspnoea index in a large randomized controlled trial: results from the scleroderma lung study. Rheumatology. 2009;48(12):1537-1540.
21.
VillalbaWOSampaio-BarrosPDPereiraMCet al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131(1):217-222.
22.
SomeyaFMugiiNHasegawaMet al. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease. Respir Care. 2014;59(1):75-80.
23.
GualtierottiRScaloneLIngegnoliFet al. Health related quality of life assessment in patients with systemic sclerosis. Reumatismo. 2010;62(3):210-214.
24.
WareJEJrSherbourneCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
25.
DuruozMTPoiraudeauSFermanianJet al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23(7):1167-1172.
26.
Maddali-BongiSDel RossoAGalluccioFet al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol. 2009;28(10):1167-1173.
27.
Maddali-BongiSDel RossoAGalluccioFet al. Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol. 2009;27(3Suppl. 54):44-50.
28.
NishiyamaOTaniguchiHKondohYet al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?Respir Med. 2005;99(4):408-414.
29.
ChangJACurtisJRPatrickDLet al. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116(5):1175-1182.
30.
TzanakisNSamiouMLambiriIet al. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med. 2005;16(2):105-112.
31.
NagataKTomiiKOtsukaKet al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology. 2012;17(3):506-512.
32.
MahlerDAWeinbergDHWellsCKet al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751-758.
33.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
34.
EatonTYoungPMilneDet al. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005;171(10):1150-1157.
35.
BuchMHDentonCPFurstDEet al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann Rheum Dis. 2007;66(2):169-173.
36.
GarinMCHighlandKBSilverRMet al. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009;36(2):330-336.
37.
LamaVNFlahertyKRToewsGBet al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168(9):1084-1090.
38.
AlbiliaJBLamDKBlanasNet al. Small mouths … Big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc. 2007;73(9):831-836.
39.
SchnitzerMHudsonMBaronMet al. Disability in systemic sclerosis: a longitudinal observational study. J Rheumatol. 2011;38(4):685-692.
40.
Van LankveldWGVonkMCTeunissenHet al. Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology. 2007;46(5):872-876.
41.
PaquetteDLFalangaV.Cutaneous concerns of scleroderma patients. J Dermatol. 2003;30(6):438-443.
42.
Del RossoAMaddali-BongiS. Oral health in patients with systemic sclerosis. Rheumatology. 2014;53(8):1355-1356.
43.
SandqvistGEklundMAkessonAet al. Daily activities and hand function in women with scleroderma. Scand J Rheumatol. 2004;33(2):102-107.
44.
SandqvistGSchejaAEklundM.Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatology. 2008;47(11):1708-1711.
45.
SandqvistGSchejaAHesselstrandR.Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology. 2010;49(9):1739-1746.
46.
PooleJL.Grasp pattern variations seen in the scleroderma hand. Am J Occup Ther. 1994;48(1):46-54.
47.
MugiiNHasegawaMMatsushitaTet al. The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. J Rheumatol. 2006;33(8):1586-1592.
48.
SandqvistGAkessonAEklundM.Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil. 2004;26(16):981-987.
49.
Maddali-BongiSDel RossoAPassalacquaMet al. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res. 2011;63(8):1134-1141.
50.
NaylorWPDouglassCWMixE.The nonsurgical treatment of microstomia in scleroderma: a pilot study. Oral Surg Oral Med Oral Pathol. 1984;57(5):508-511.
51.
PizzoGScardinaGAMessinaP.Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003;7(3):175-178.
52.
YuenHKMarlowNMReedSGet al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012;34(1):84-89.
53.
Maddali-BongiSLandiGGalluccioFet al. The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat’s technique and kinesiotherapy: a randomized controlled trial. Rheumatol Int. 2011;31(7):895-901.
54.
Maddali-BongiSMatucci CerinicM.Rheumatologic rehabilitation: the great expectation for rheumatic patients. Reumatismo. 2012;64(1):1-6.
55.
De OliveiraNCPortesLAPetterssonHet al. Aerobic and resistance exercise in systemic sclerosis: state of the art. Musculoskeletal Care. 2017;15(4):316-323.
56.
AlexandersonHBergegardJBjornadalLet al. Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study. BMC Res Notes. 2014;7:86.
57.
AntonioliCMBuaGFrigeAet al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol. 2009;28(2):159-165.
58.
RannouFBoutronIMouthonLet al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res. 2017;69(7):1050-1059.
59.
SteenVDConteCOwensGRet al. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1994;37(9):1283-1289.
60.
NishiyamaOKondohYKimuraTet al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394-399.
61.
MugiiNSomeyaFHasegawaM.Reduced hypoxia risk in a systemic sclerosis patient with interstitial lung disease after long-term pulmonary rehabilitation. Clin Med Insights Case Rep. 2011;4:53-56.
62.
SomeyaFMugiiN.Pulmonary rehabilitation outcome of exercise-induced oxygen desaturation in systemic sclerosis with interstitial lung disease. Health. 2013;5:1-5.
63.
ShoemakerMJWiltJLDasguptaRet al. Exercise training in patients with pulmonary arterial hypertension: a case report. Cardiopulm Phys Ther J. 2009;20(4):12-18.
64.
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2Pt 1):646-664.
